Clinical Trial Update: The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing 50% AS versus PFAT+ 0.05% COE in severe dry eye syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• 50% AS
• PFAT+ 0.05% COE

Snippet

Sponsor: Seref istek | Conditions: Dry Eye Syndrome | Phase 4 | Status: COMPLETED